Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRT-2761 in allergic conjunctivitis
NCT03320434Phase 2Completed
- Start
- Oct 2017
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of prt-2761 in allergic conjunctivitis (AC). Started Oct 2017; status: completed.
02
Drugs
prt-2761
03
Conditions
allergic conjunctivitis (AC)
Beyond the preview
Go deeper on NCT03320434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03320434.